Aberrant p53 Expression Does Not Correlate with the Prognosis in Anaplastic Astrocytoma
- 1 August 1995
- journal article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 37 (2) , 246-254
- https://doi.org/10.1227/00006123-199508000-00009
Abstract
MUTATIONS OF THE p53 tumor-suppressor gene, as determined by the immunohistochemistry of archival formalin-fixed specimens, have been correlated withKeywords
This publication has 45 references indexed in Scilit:
- p53 in Low-grade GliomasInternational Journal of Surgical Pathology, 1994
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- ras-Induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutationCell, 1992
- Photodynamic Therapy of Cerebral TumorsNeurosurgery Quarterly, 1991
- Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: a Ki‐67 studyNeuropathology and Applied Neurobiology, 1990
- Supratentorial anaplastic gliomas in adultsJournal of Neurosurgery, 1989
- Prognostic Factors in Well-Differentiated Cerebral Astrocytomas in the AdultNeurosurgery, 1989
- Prognostic implications of the proliferative potential of low-grade astrocytomasJournal of Neurosurgery, 1988
- Neurosurgical management of low-grade astrocytoma of the cerebral hemispheresJournal of Neurosurgery, 1984
- The Relatively Benign Astrocytomas of the CerebrumJournal of Neurosurgery, 1961